Details of the Drug Reposition

General Information of This Drug (ID: DMMJZ2E)

Drug Name
PF-07104091   DMMJZ2E
Drug Type
Small molecular drug

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Non-small-cell lung cancer DISI0V1B 2C25 Phase 1 [1]
Triple negative breast cancer DISAMG6N 2C60-2C65 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT04553133) PF-07104091 as a Single Agent and in Combination Therapy. U.S. National Institutes of Health.